Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TYK MedicinesHKSE:02410 -4.08%7 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates HKSE:02410 with a GF Score™ of 7/100. The stock has 3 warning signs investors should review. Among 703 Biotechnology companies, TYK Medicines ranks worse than 142247.37% on this metric.
The historical rank and industry rank for TYK Medicines's Days Payable or its related term are showing as below:
During the past 4 years, TYK Medicines's highest Days Payable was 103518.06. The lowest was 145.76. And the median was 51831.91.
HKSE:02410's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84 * Ranked among companies with meaningful Days Payable only.
TYK Medicines's Days Payable
declined
from Dec. 2024 (48,675.88) to Dec. 2025 (0.00).
It may suggest that TYK Medicinesaccelerated paying its suppliers.
The historical data trend for TYK Medicines's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02410 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, TYK Medicines's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TYK Medicines Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TYK Medicines's Days Payable distribution charts can be found below:
* The bar in red indicates where TYK Medicines's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TYK Medicines's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TYK Medicines (HKSE:02410) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TYK Medicines and its competitors. Over the past decade, TYK Medicines' Days Payable has ranged from 145.76 to 103,518.06. According to the industry distribution chart, TYK Medicines ranks #999999 out of 703 companies in the Biotechnology industry.
Is TYK Medicines' Days Payable too high?
TYK Medicines' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 145.76 to a high of 103,518.06. Based on the distribution chart, TYK Medicines ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TYK Medicines has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does TYK Medicines' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TYK Medicines ranks #999999 out of 703 companies for Days Payable. This places TYK Medicines in the lower half of its industry. The industry median Days Payable is 112.84. Historically, TYK Medicines' own Days Payable has ranged from 145.76 to 103,518.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TYK Medicines and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TYK Medicines's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TYK Medicines stock overvalued right now?
TYK Medicines (HKSE:02410) has a current Days Payable of 0.00. The current Days Payable is 0.00. TYK Medicines' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TYK Medicines (HKSE:02410), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TYK Medicines Inc is a clinical-stage biopharmaceutical company. The company is engaged in drug discovery research and development. The company and its subsidiaries are principally engaged in the research, development, and commercialization of pharmaceutical products. The company has built a pipeline with10 drug candidates, including Core Product TY-9591, five clinical stage products, and four preclinical stage or early clinical development stage.
7GF Score
Get the complete analysis for HKSE:02410
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02410 has been successfully added to your 
